What is the share price of Auro Laboratories Ltd (AUROLAB) today?

The share price of AUROLAB as on 7th October 2026 is ₹232.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Auro Laboratories Ltd (AUROLAB) share?

The past returns of Auro Laboratories Ltd (AUROLAB) share are Past 1 week: -1.04%Past 1 month: -9.25%Past 3 months: -6.92%Past 6 months: -10.37%Past 1 year: 5.80%Past 3 years: 91.05%Past 5 years: 73.65%

What are the peers or stocks similar to Auro Laboratories Ltd (AUROLAB)?

The peers or stocks similar to Auro Laboratories Ltd (AUROLAB) include: Auro Laboratories Ltd Sun Pharmaceutical Industries Ltd Torrent Pharmaceuticals Ltd Zydus Lifesciences Ltd Laurus Labs Ltd Cipla Ltd

What is the market cap of Auro Laboratories Ltd (AUROLAB) share?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Auro Laboratories Ltd (AUROLAB) is ₹142.01 Cr as of 7th October 2026.

What is the 52 week high and low of Auro Laboratories Ltd (AUROLAB) share?

The 52-week high of Auro Laboratories Ltd (AUROLAB) is ₹317 and the 52-week low is ₹159.

What is the PE and PB ratio of Auro Laboratories Ltd (AUROLAB) stock?

The P/E (price-to-earnings) ratio of Auro Laboratories Ltd (AUROLAB) is 40.23. The P/B (price-to-book) ratio is 3.06.

Which sector does Auro Laboratories Ltd (AUROLAB) belong to?

Auro Laboratories Ltd (AUROLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.

How to buy Auro Laboratories Ltd (AUROLAB) shares?

You can directly buy Auro Laboratories Ltd (AUROLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Auro Laboratories Ltd

AUROLAB Share Price

BSE

₹232.600.91% (+2.10)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹142 cr, stock is ranked 3,005

High Risk

Stock is 3.62x as volatile as Nifty

AUROLAB Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹142 cr, stock is ranked 3,005

High Risk

Stock is 3.62x as volatile as Nifty

AUROLAB Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
30.15	3.06	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
45.85	5.74	0.50%

AUROLAB Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AUROLAB Company Profile

Auro Laboratories Limited is engaged in the business of bulk drugs. It manufactures active pharmaceutical ingredients (APIs), intermediates and generic formulations.

AUROLAB Similar Stocks (Peers)

Compare with peers Compare with peers

AUROLAB Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

37.71

1Y Return

7.68%

Buy Reco %

93.33

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

83.90

1Y Return

32.60%

Buy Reco %

81.48

Zydus Lifesciences Ltd

ZYDUSLIFE

PE Ratio

22.95

1Y Return

17.21%

Buy Reco %

57.69

Laurus Labs Ltd

LAURUSLABS

PE Ratio

124.62

1Y Return

137.68%

Buy Reco %

58.33

Cipla Ltd

CIPLA

PE Ratio

27.91

1Y Return

12.01%

Buy Reco %

62.86

Compare with Peers

AUROLAB Forecast

AUROLAB Forecasts

AUROLAB

Income

Balance Sheet

Cash Flow

Financial Year		FY 2018		FY 2019		FY 2020		FY 2021		FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	TTM
Total Revenue	41.30	47.78	44.76	55.01	51.96	53.83	55.14	20.05	32.75	38.76
Raw Materials	24.66	30.39	23.99	27.64	33.76	37.30	29.04	5.08	14.29	23.92
Power & Fuel Cost	1.48	1.64	1.69	1.60	1.67	2.08	2.43	0.33	1.85
Employee Cost	2.80	2.87	3.48	3.64	3.70	3.76	3.91	2.47	5.86
Selling & Administrative Expenses	3.27	4.18	5.03	5.84	5.86	4.73	7.91	2.89	5.44
Operating & Other expenses	2.23	0.75	3.33	4.29	1.25	0.63	-0.32	5.23	-6.56
EBITDA	6.86	7.95	7.24	12.00	5.72	5.33	12.17	4.05	11.87	14.84
Depreciation/Amortization	0.93	1.01	1.02	1.04	1.02	1.07	1.09	1.10	2.81	3.44
PBIT	5.93	6.94	6.22	10.96	4.70	4.26	11.08	2.95	9.06	11.40
Interest & Other Items	1.21	0.87	0.58	0.46	0.83	0.81	0.74	1.08	4.25	5.34
PBT	4.72	6.07	5.64	10.50	3.87	3.45	10.34	1.87	4.81	6.06
Taxes & Other Items	1.19	1.67	1.58	3.32	1.03	1.00	2.55	0.04	1.28	1.35
Net Income	3.53	4.40	4.06	7.18	2.84	2.45	7.79	1.83	3.53	4.71
EPS	5.66	7.06	6.51	11.52	4.56	3.93	12.50	2.94	5.66	7.56
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

AUROLAB Income Statement

Quarter		mar 2024		jun 2024		sep 2024		dec 2024		mar 2025	jun 2025	sep 2025	dec 2025	mar 2026	jun 2026
Total Revenue	12.46	5.92	3.41	3.20	7.53	3.19	9.81	9.57	10.50	8.88
Operating & Other expenses	9.65	4.40	2.38	2.61	6.59	2.74	6.48	5.33	6.65	5.46
EBITDA	2.81	1.52	1.03	0.59	0.94	0.45	3.33	4.24	3.85	3.42
Depreciation/Amortization	0.28	0.27	0.27	0.27	0.29	0.27	0.65	0.98	0.90	0.91
PBIT	2.53	1.25	0.76	0.32	0.65	0.18	2.68	3.26	2.95	2.51
Interest & Other Items	-0.32	0.25	0.28	0.25	0.30	0.28	0.96	1.52	1.49	1.37
PBT	2.85	1.00	0.48	0.07	0.35	-0.10	1.72	1.74	1.46	1.14
Taxes & Other Items	0.53	0.25	0.12	0.02	-0.04	0.00	1.00	-0.21	0.48	0.08
Net Income	2.32	0.75	0.36	0.05	0.39	-0.10	0.72	1.95	0.98	1.06
EPS	3.72	1.21	0.57	0.08	0.63	-0.17	1.15	3.13	1.56	1.68

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Cash from Operating Activities	6.49	6.05	6.87	9.30	12.82	-6.59	3.28	18.81	5.02	2.11
Cash from Investing Activities	-2.20	-3.04	-3.19	-2.21	-3.51	-5.34	-5.08	-38.67	-23.70	-14.78
Cash from Financing Activities	-3.81	-1.77	-1.83	-5.52	-0.46	9.79	-8.18	19.09	17.69	14.04
Net Change in Cash	+0.48	+1.24	+1.85	+1.57	+8.85	-2.14	-9.98	-0.77	-0.99	+1.37
Changes in Working Capital	+1.68	-0.70	-0.92	+2.02	+0.98	-12.06	-2.29	+6.37	+1.24	-9.81
Capital Expenditures	1.63	1.80	1.62	0.67	0.38	4.61	4.07	35.64	23.80	57.14
Free Cash Flow	4.86	4.25	5.25	8.63	12.44	-11.20	-0.79	-16.83	-18.78	-55.03

AUROLAB Company Updates

FY 2026FY 2026

Annual report

PDF

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

AUROLAB Stock Peers

AUROLAB Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Auro Laboratories Ltd	40.23	3.06	—
Sun Pharmaceutical Industries Ltd	37.71	5.16	0.89%
Torrent Pharmaceuticals Ltd	83.90	10.32	0.71%
Zydus Lifesciences Ltd	22.95	3.91	0.09%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Auro Laboratories Ltd	Pro
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Auro Laboratories Ltd	48.62%	36.66	Pro
Sun Pharmaceutical Industries Ltd	20.14%	44.91
Torrent Pharmaceuticals Ltd	22.81%	44.75
Zydus Lifesciences Ltd	23.86%	64.24

AUROLAB Stock Price Comparison

Compare AUROLAB with any stock or ETF

AUROLAB

AUROLAB Holdings

AUROLAB Shareholdings

AUROLAB Promoter Holdings Trend

AUROLAB Institutional Holdings Trend

AUROLAB Shareholding Pattern

AUROLAB Shareholding History

Foreign Institutions

AUROLAB Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing AUROLAB stock

Looks like this stock is not in any smallcase yet.

AUROLAB Events

AUROLAB Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

AUROLAB Dividend Trend

AUROLAB Dividends

Hmm, looks like data is unavailable here. Please come back after some time

AUROLAB Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Insider Trading / SAST

Announced OnSep 23, 2026

Auro Laboratories Ltd - 530233 - Closure

Auro Laboratories Ltd - 530233 - Closure Download

Link

Download

Announced On

Sep 23, 2026

Company Update

Announced OnAug 17, 2026

Auro Laboratories Ltd - 530233 - Announc

Auro Laboratories Ltd - 530233 - Announc Download

Link

Download

Announced On

Aug 17, 2026

Result

Announced OnAug 14, 2026

Auro Laboratories Ltd - 530233 - Un-Aud

Auro Laboratories Ltd - 530233 - Un-Aud Download

Link

Download

Announced On

Aug 14, 2026

Board Meeting

Announced OnAug 14, 2026

Auro Laboratories Ltd - 530233 - Board M

Auro Laboratories Ltd - 530233 - Board M Download

Link

Download

Announced On

Aug 14, 2026

AGM/EGM

Announced OnAug 13, 2026

Auro Laboratories Ltd - 530233 - Shareho

Auro Laboratories Ltd - 530233 - Shareho Download

Link

Download

Announced On

Aug 13, 2026

AUROLAB Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

AUROLAB Stock News & Opinions

Corporate

Auro Laboratories to convene AGM

Auro Laboratories announced that the 37th Annual General Meeting(AGM) of the company will be held on 11 August 2026.

3 months agoCapital Market - Live

Earnings

Auro Laboratories standalone net profit rises 148.72% in the March 2026 quarter

Net profit of Auro Laboratories rose 148.72% to Rs 0.97 crore in the quarter ended March 2026 as against Rs 0.39 crore during the previous quarter ended March 2025. Sales rose 32.84% to Rs 9.83 crore in the quarter ended March 2026 as against Rs 7.40 crore during the previous quarter ended March 2025. For the full year,net profit rose 91.85% to Rs 3.53 crore in the year ended March 2026 as against Rs 1.84 crore during the previous year ended March 2025. Sales rose 58.45% to Rs 30.74 crore in the year ended March 2026 as against Rs 19.40 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales9.837.40 33 30.7419.40 58 OPM %33.7710.95 -32.5317.53 - PBDT2.490.64 289 7.762.98 160 PBT1.590.35 354 4.951.88 163 NP0.970.39 149 3.531.84 92 Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Auro Laboratories to hold board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2026.

4 months agoCapital Market - Live

Earnings

Auro Laboratories standalone net profit rises 3800.00% in the December 2025 quarter

Net profit of Auro Laboratories rose 3800.00% to Rs 1.95 crore in the quarter ended December 2025 as against Rs 0.05 crore during the previous quarter ended December 2024. Sales rose 207.87% to Rs 9.39 crore in the quarter ended December 2025 as against Rs 3.05 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales9.393.05 208 OPM %43.2414.75 - PBDT2.720.34 700 PBT1.740.07 2386 NP1.950.05 3800 Powered by Capital Market - Live

8 months agoCapital Market - Live

Corporate

Auro Laboratories to announce Quarterly Result

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live

8 months agoCapital Market - Live

Earnings

Auro Laboratories standalone net profit rises 100.00% in the September 2025 quarter

Net profit of Auro Laboratories rose 100.00% to Rs 0.72 crore in the quarter ended September 2025 as against Rs 0.36 crore during the previous quarter ended September 2024. Sales rose 185.16% to Rs 8.84 crore in the quarter ended September 2025 as against Rs 3.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.843.10 185 OPM %26.5823.23 - PBDT2.370.75 216 PBT1.720.48 258 NP0.720.36 100 Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Auro Laboratories to discuss results

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Auro Laboratories AGM scheduled

Auro Laboratories announced that the 36th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Earnings

Auro Laboratories reports standalone net loss of Rs 0.11 crore in the June 2025 quarter

Net loss of Auro Laboratories reported to Rs 0.11 crore in the quarter ended June 2025 as against net profit of Rs 0.75 crore during the previous quarter ended June 2024. Sales declined 51.57% to Rs 2.77 crore in the quarter ended June 2025 as against Rs 5.72 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2.775.72 -52 OPM %0.7223.08 - PBDT0.161.27 -87 PBT-0.111.00 PL NP-0.110.75 PL Powered by Capital Market - Live

1 year agoCapital Market - Live

Corporate

Auro Laboratories to hold board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

What is the share price of Auro Laboratories Ltd (AUROLAB) today?
The share price of AUROLAB as on 7th October 2026 is ₹232.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Auro Laboratories Ltd (AUROLAB) share?
The past returns of Auro Laboratories Ltd (AUROLAB) share are
- Past 1 week: -1.04%
- Past 1 month: -9.25%
- Past 3 months: -6.92%
- Past 6 months: -10.37%
- Past 1 year: 5.80%
- Past 3 years: 91.05%
- Past 5 years: 73.65%
What are the peers or stocks similar to Auro Laboratories Ltd (AUROLAB)?
The peers or stocks similar to Auro Laboratories Ltd (AUROLAB) include:
What is the market cap of Auro Laboratories Ltd (AUROLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Auro Laboratories Ltd (AUROLAB) is ₹142.01 Cr as of 7th October 2026.
What is the 52 week high and low of Auro Laboratories Ltd (AUROLAB) share?
The 52-week high of Auro Laboratories Ltd (AUROLAB) is ₹317 and the 52-week low is ₹159.
What is the PE and PB ratio of Auro Laboratories Ltd (AUROLAB) stock?
The P/E (price-to-earnings) ratio of Auro Laboratories Ltd (AUROLAB) is 40.23. The P/B (price-to-book) ratio is 3.06.
Which sector does Auro Laboratories Ltd (AUROLAB) belong to?
Auro Laboratories Ltd (AUROLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Auro Laboratories Ltd (AUROLAB) shares?
You can directly buy Auro Laboratories Ltd (AUROLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.